Gene · 1491
Papers3,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between altered metabolism and genetic mutations in human glioma. | Cancer Rep (Hoboken) | 2023 | 36916606 | PubTator, text mining | PubMed |
| Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem. | Mikrochim Acta | 2023 | 36914921 | PubTator, text mining | PubMed |
| Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway. | Redox Biol | 2023 | 36913800 | PubTator, text mining | PubMed |
| Role of ferroptosis in colorectal cancer. | World J Gastrointest Oncol | 2023 | 36908317 | PubTator, text mining | PubMed |
| B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis. | Signal Transduct Target Ther | 2023 | 36907919 | PubTator, text mining | PubMed |
| Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology. | Int J Mol Sci | 2023 | 36902112 | PubTator, text mining | PubMed |
| Update on the Pathogenesis of the Hirschsprung-Associated Enterocolitis. | Int J Mol Sci | 2023 | 36902033 | PubTator, text mining | PubMed |
| Current and Novel Therapeutical Approaches of Classical Homocystinuria in Childhood With Special Focus on Enzyme Replacement Therapy, Liver-Directed Therapy and Gene Therapy. | J Clin Med Res | 2023 | 36895619 | PubTator, text mining | PubMed |
| The role of rhoA/rho-kinase and PKC in the inhibitory effect of L-cysteine/H2S pathway on the carbachol-mediated contraction of mouse bladder smooth muscle. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 36894621 | PubTator, text mining | PubMed |
| Structural basis of the inhibition of cystathionine γ-lyase from Toxoplasma gondii by propargylglycine and cysteine. | Protein Sci | 2023 | 36883335 | PubTator, text mining | PubMed |
| Hydrogen sulfide in health and diseases: cross talk with noncoding RNAs. | Am J Physiol Cell Physiol | 2023 | 36878842 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| CTH/MPST double ablation results in enhanced vasorelaxation and reduced blood pressure via upregulation of the eNOS/sGC pathway. | Front Pharmacol | 2023 | 36860295 | PubTator, text mining | PubMed |
| Enlightening the Path to Protein Engineering: Chemoselective Turn-On Probes for High-Throughput Screening of Enzymatic Activity. | Chem Rev | 2023 | 36853077 | PubTator, text mining | PubMed |
| Cystathionine-γ-lyase overexpression modulates oxidized nicotinamide adenine dinucleotide biosynthesis and enhances neovascularization. | JVS Vasc Sci | 2023 | 36852171 | PubTator, text mining | PubMed |
| Ratiometric Near-Infrared Fluorescence Liposome Nanoprobe for H2S Detection In Vivo. | Molecules | 2023 | 36838886 | PubTator, text mining | PubMed |
| Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics. | Micromachines (Basel) | 2023 | 36838091 | PubTator, text mining | PubMed |
| The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder. | J Pers Med | 2023 | 36836486 | PubTator, text mining | PubMed |
| Bioinorganic Modulators of Ferroptosis: A Review of Recent Findings. | Int J Mol Sci | 2023 | 36835045 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underlying Vertebrate Adaptive Evolution: A Systematic Review. | Genes (Basel) | 2023 | 36833343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1491/papers?page=19